跳至主要内容
临床试验/JPRN-UMIN000050499
JPRN-UMIN000050499已完成Unknown

Ozempic Retrospective study, Investigation from real-world data of GLP-1 receptor Agonist, semaglutide, Multicenter trial In Japan - ORIGAMI study

Toho University Omori Medical Center0 个研究点目标入组 700 人开始时间: 2023年3月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fall into any of the following criteria are excluded from participating in the study; 1. Patients with type 1 diabetes mellitus 2. Patients with excessive drinking of alcohol (net alcohol intake is more than 60g/day for male or 30g/day for female) 3. Patients with dementia 4. Patients who were pregnant during data collection period 5. Patients who were hospitalized for a week or longer within 52 weeks after the initial date 6. Patients with poor medication adherence (judged by attending physician) 7. Patients with other conditions that the attending physician think inappropriate to participate in the study

研究者

相似试验